Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/6/23 16:37 | 4/4/23 | JNCE | Health | BioPrd | Biological Products, (No Diag | Murray Richard /Ca/ | MA | D | S | -73 | 1.85 | 0 | -39 | -17 | 189 | D | |||||||||||||||
3/14/23 20:39 | 3/13/23 | JNCE | Health | BioPrd | Biological Products, (No Diag | Tang Kevin C | CA | T | P.m | 86 | 0.9997 | 0 | 86 | 2 | 5,300 | I | |||||||||||||||
1/11/23 20:33 | 1/9/23 | JNCE | Health | BioPrd | Biological Products, (No Diag | Trehu Elizabeth | MA | O | Chief Me | S.m | -10 | 1.11 | 0 | -9 | -8 | 103 | D | ||||||||||||||
1/11/23 20:32 | 1/9/23 | JNCE | Health | BioPrd | Biological Products, (No Diag | Murray Richard /ca/ | MA | DO | CEO,P | S.m | -50 | 1.11 | 0 | -45 | -17 | 228 | D | ||||||||||||||
1/11/23 20:30 | 1/9/23 | JNCE | Health | BioPrd | Biological Products, (No Diag | Drapkin Kimberlee C | MA | O | CFO,Trea | S.m | -16 | 1.11 | 0 | -14 | -18 | 66 | D | ||||||||||||||
1/11/23 20:29 | 1/9/23 | JNCE | Health | BioPrd | Biological Products, (No Diag | Cole Hugh M | MA | O | COO | S.m | -18 | 1.11 | 0 | -17 | -13 | 110 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |